These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10869 related articles for article (PubMed ID: 10845554)

  • 1. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
    Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R
    Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
    Béliveau R; Delbecchi L; Beaulieu E; Mousseau N; Kachra Z; Berthelet F; Moumdjian R; Del Maestro R
    Ann N Y Acad Sci; 1999; 886():236-9. PubMed ID: 10667228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.
    Mohanam S; Wang SW; Rayford A; Yamamoto M; Sawaya R; Nakajima M; Liotta LA; Nicolson GL; Stetler-Stevenson WG; Rao JS
    Clin Exp Metastasis; 1995 Jan; 13(1):57-62. PubMed ID: 7820957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
    Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
    Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.
    Pagenstecher A; Wussler EM; Opdenakker G; Volk B; Campbell IL
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):598-612. PubMed ID: 11398836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
    Thorns V; Walter GF; Thorns C
    Anticancer Res; 2003; 23(5A):3937-44. PubMed ID: 14666700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
    Guo W; Chen G; Zhu C; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
    Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
    J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
    J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
    Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
    Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
    Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 544.